(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one

C20H18N2O3S — CID 127045607

IUPAC(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one
SMILESCN1C(=S)N(c2ccc3c(c2)CCC3)C(=O)/C1=C/c1ccc(O)cc1O
InChIInChI=1S/C20H18N2O3S/c1-21-17(10-14-6-8-16(23)11-18(14)24)19(25)22(20(21)26)15-7-5-12-3-2-4-13(12)9-15/h5-11,23-24H,2-4H2,1H3/b17-10-
InChIKeyMJJSYWVUFGCDIG-YVLHZVERSA-N
MW366.44 g/mol
LogP3.19
Rot. Bonds2

About (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one

(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one (PubChem CID 127045607) has the molecular formula C20H18N2O3S and a molecular weight of 366.44 g/mol. Its IUPAC name is (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one.

Molecular Properties

Compound Name(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one
PubChem CID127045607
Molecular FormulaC20H18N2O3S
Molecular Weight366.44 g/mol
Exact Mass366.10
IUPAC Name(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one
SMILESCN1C(=S)N(c2ccc3c(c2)CCC3)C(=O)/C1=C/c1ccc(O)cc1O
InChIInChI=1S/C20H18N2O3S/c1-21-17(10-14-6-8-16(23)11-18(14)24)19(25)22(20(21)26)15-7-5-12-3-2-4-13(12)9-15/h5-11,23-24H,2-4H2,1H3/b17-10-
InChIKeyMJJSYWVUFGCDIG-YVLHZVERSA-N
XLogP3.19
TPSA64.01 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500366.44
LogP ≤ 53.19
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one?
The IUPAC name of (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one (CID 127045607) is (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one.
What is the SMILES notation for (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one?
The canonical SMILES for (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one is CN1C(=S)N(c2ccc3c(c2)CCC3)C(=O)/C1=C/c1ccc(O)cc1O.
What is the InChIKey of (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one?
The InChIKey is MJJSYWVUFGCDIG-YVLHZVERSA-N. The full InChI is InChI=1S/C20H18N2O3S/c1-21-17(10-14-6-8-16(23)11-18(14)24)19(25)22(20(21)26)15-7-5-12-3-2-4-13(12)9-15/h5-11,23-24H,2-4H2,1H3/b17-10-.
What are the key properties of (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one?
(5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one has a molecular weight of 366.44 g/mol, XLogP of 3.19, 2 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (5Z)-3-(2,3-dihydro-1H-inden-5-yl)-5-[(2,4-dihydroxyphenyl)methylidene]-1-methyl-2-sulfanylideneimidazolidin-4-one is sourced from PubChem (CID 127045607), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).